National Cancer Institute; Notice of Closed Meeting, 9542 [07-970]
Download as PDF
<![CDATA[
9542
Federal Register / Vol. 72, No. 41 / Friday, March 2, 2007 / Notices
released at the meeting. There also will
be updates on the Committee’s draft
report on pharmacogenomics and
several Federal initiatives and activities.
Time will be provided each day for
public comments. The Committee
would welcome hearing from anyone
wishing to provide public comments on
any issue related to genetics, health and
society. Individuals who would like to
provide public comment should notify
the SACGHS Executive Secretary, Ms.
Sarah Carr, by telephone at 301–496–
9838 or e-mail at sc112c@nih.gov. The
SACGHS office is located at 6705
Rockledge Drive, Suite 750, Bethesda,
MD 20892. Anyone planning to attend
the meeting, who is in need of special
assistance, such as sign language
interpretation or other reasonable
accommodations, is also asked to
contact the Executive Secretary.
Under authority of 42 U.S.C. 217a,
Section 222 of the Public Health Service
Act, as amended, the Department of
Health and Human Services established
SACGHS to serve as a public forum for
deliberations on the broad range of
human health and societal issues raised
by the development and use of genetic
and genomic technologies and, as
warranted, to provide advice on these
views. The draft meeting agenda and
other information about SACGHS,
including information about access to
the Web cast, will be available at the
following Web site: https://
www4.od.nih.gov/oba/sacghs.htm.
Dated: February 22, 2007.
Anna Snouffer,
Acting Director, NIH Office of Federal
Advisory Committee Policy.
[FR Doc. 07–965 Filed 3–1–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
new agent development contract
resources for the preclinical
development of drugs and biologics.
The outcome of the evaluation will be
a decision whether NCI should support
the request and make available contract
resources for support through the RAID
program to the research community and
NCI new agent development for the
preclinical development of drugs and
biologics. The research proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the
proposed research projects, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Rapid
Access to Intervention Development.
Date: March 20–21, 2007.
Time: 1 p.m.–5 p.m.
Agenda: To evaluate the Rapid Access to
Intervention Development Portfolio.
Place: National Institutes of Health,
Executive Plaza North, Conference Room J,
6130 Executive Boulevard, Rockville, MD
20852.
Contact Person: Phyllis G. Bryant,
Executive Secretary, Program Analyst,
Developmental Therapeutics Program,
National Cancer Institute, NIH, 6130
Executive Boulevard, Rm. 8022, Bethesda,
MD 20892. (301) 496–8720.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 22, 2007
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–968 Filed 3–1–07; 8:45 am]
pwalker on PROD1PC71 with NOTICES
National Cancer Institute; Notice of
Closed Meeting
BILLING CODE 4140–01–M
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The purpose of this
meeting is to evaluate proposals for
support through the RAID program by
making available to the research
community, on a competitive basis, NCI
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Aug<31>2005
18:44 Mar 01, 2007
Jkt 211001
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors for Basic
Sciences National Cancer Institute. The
meeting will be closed to the public as
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
indicated below in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Cancer Institute, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors for Basic Sciences National
Cancer Institute.
Date: March 4–5, 2007.
Time: March 4, 2007, 6 p.m. to 10:15 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Double Tree Hotel, 8120 Wisconsin
Avenue, Bethesda, MD 20814.
Time: March 5, 2007, 8 a.m. to 10 a.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
National Cancer Institute, 9000 Rockville
Pike, Building 31, Conference Room 6,
Bethesda, MD 20892.
Contact Person: Florence E. Farber, PhD,
Executive Secretary, Office of the Director,
National Cancer Institute, National Institutes
of Health, 6116 Executive Boulevard, Room
2115, Bethesda, MD 20892, 301–496–7628,
ff6p@nih.gov.
This notice is being published less than 15
days prior to meeting due to scheduling
conflicts.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 23, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–970 Filed 3–1–07; 8:45 am]
BILLING CODE 4140–01–M
E:\FR\FM\02MRN1.SGM
02MRN1
]]>Agencies
[Federal Register Volume 72, Number 41 (Friday, March 2, 2007)]
[Notices]
[Page 9542]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-970]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Board of Scientific Counselors for Basic Sciences National Cancer
Institute. The meeting will be closed to the public as indicated below
in accordance with the provisions set forth in section 552b(c)(6),
Title 5 U.S.C., as amended for the review, discussion, and evaluation
of individual intramural programs and projects conducted by the
National Cancer Institute, including consideration of personnel
qualifications and performance, and the competence of individual
investigators, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors for Basic
Sciences National Cancer Institute.
Date: March 4-5, 2007.
Time: March 4, 2007, 6 p.m. to 10:15 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: Double Tree Hotel, 8120 Wisconsin Avenue, Bethesda, MD
20814.
Time: March 5, 2007, 8 a.m. to 10 a.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, National Cancer Institute,
9000 Rockville Pike, Building 31, Conference Room 6, Bethesda, MD
20892.
Contact Person: Florence E. Farber, PhD, Executive Secretary,
Office of the Director, National Cancer Institute, National
Institutes of Health, 6116 Executive Boulevard, Room 2115, Bethesda,
MD 20892, 301-496-7628, ff6p@nih.gov.
This notice is being published less than 15 days prior to
meeting due to scheduling conflicts.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer
Construction; 93.393, Cancer Cause and Prevention Research; 93.394,
Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment
Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers
Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control,
National Institutes of Health, HHS)
Dated: February 23, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-970 Filed 3-1-07; 8:45 am]
BILLING CODE 4140-01-M
